Clinical trial · Observational
Analgesic Treatment for Cancer Pain in South East Asia
A Cross-sectional Study to Investigate the Pain Control Status in Cancer Patients in South East Asian Countries
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is planned to investigate the pain control status in cancer patients in 6 South East Asian countries through evaluation of prescription pattern of analgesics, satisfaction of pain control, quality of life and assessment of the adequacy of pain control and relationship among these factors in cancer patients with pain. Cancer pain is undermanaged and it is hoped that this study will be used as a reference for effective cancer pain management in these countries.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patients receiving cancer pain treatment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients receiving cancer pain treatment
- interventionNames
- Other: Patients receiving cancer pain treatment
Primary outcomes (4)
- measure
- Prescription Pattern of Analgesics (Opioid or Non-opioid)
- timeFrame
- Day 1
- description
- At Visit 1 (Day 1) which was the only visit in the study, data was collected on whether each patient was receiving only opioid, only non-opioid or both opioid and non-opioid analgesic treatments for pain control.
- measure
- Satisfaction With Patient's Pain Control as Measured by 5-point Scale Answered by Patients and Investigators
- timeFrame
- Day 1
- description
- The scale used to measure a patient's satisfaction with pain control ranges from 1 to 5: 1. Very satisfied 2. Satisfied 3. Acceptable 4. Dissatisfied 5. Very dissatisfied Patients and Investigators will each indicate their opinion on separate scales.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adult (over 18 years) cancer patients \[country variation would be accepted based on the definition of adults\] 2. Cancer has been diagnosed pathologically 3. Out-patients with cancer pain due to cancer itself or its treatment 4. Patients being treated with any analgesics for more than one month for the management of cancer pain at enrolment 5. Patients who are willing to voluntarily sign the study consent form Exclusion Criteria: 1. Patients who have had an operation for any reasons within 3 months prior to the enrolment 2. Patients with any oncologic emergency 3. Patients who had any interventional therapy (e.g. nerve block, neurolytic procedures) related to their cancer pain within 6 weeks of study entry 4. Insufficient ability or willingness to cooperate 5. Patients who are judged not suitable to participate in this study by the investigator 6. Patients who are participating in any other interventional clinical trials for cancer treatment or supportive care
References
Publications (2)
- DERIVEDThinh DHQ, Sriraj W, Mansor M, Tan KH, Irawan C, Kurnianda J, Nguyen YP, Ong-Cornel A, Hadjiat Y, Moon H, Javier FO. Analgesic Prescription Patterns and Pain Outcomes in Southeast Asia: Findings From the Analgesic Treatment of Cancer Pain in Southeast Asia Study. J Glob Oncol. 2018 Sep;4:1-10. doi: 10.1200/JGO.17.00055. PMID 30241271
- DERIVEDThinh DHQ, Sriraj W, Mansor M, Tan KH, Irawan C, Kurnianda J, Nguyen YP, Ong-Cornel A, Hadjiat Y, Moon H, Javier FO. Patient and Physician Satisfaction with Analgesic Treatment: Findings from the Analgesic Treatment for Cancer Pain in Southeast Asia (ACE) Study. Pain Res Manag. 2018 Apr 18;2018:2193710. doi: 10.1155/2018/2193710. eCollection 2018. PMID 29849841